News Conference News ISC 2024 AI-Based System Boosts Quality of Stroke Care and Reduces Events Todd Neale February 16, 2024
News Conference News ESC 2023 ESC Endocarditis Guidelines Get First Update in 8 Years Todd Neale August 31, 2023
News Conference News AHA 2022 ‘Agnostic’ EHR Alerts Boost VTE Prophylaxis in Hospitals and Postdischarge L.A. McKeown November 11, 2022
News Conference News ACC 2021 ACTION: Full-Dose Rivaroxaban Doesn’t Help in Hospitalized COVID-19 Todd Neale May 17, 2021
News Conference News TCT 2020 Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19 Michael O'Riordan October 14, 2020
News Conference News ESC 2020 Chinese Data Back Anticoagulants to Prevent COVID-19 Thromboembolism Caitlin E. Cox September 04, 2020
News Conference News ACC 2020 PRONOMOS: Rivaroxaban Beats Enoxaparin for Preventing VTE After Orthopedic Surgery Yael L. Maxwell March 31, 2020
News Conference News TCT 2019 Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA Todd Neale October 04, 2019
News Conference News EHRA 2019 Survey Says . . . Patients Like NOACs Better Than Warfarin Todd Neale March 17, 2019
News Conference News AHA 2018 Concerning Decline in Antibiotic Prophylaxis for Infective Endocarditis Todd Neale November 19, 2018
News Conference News ESC 2018 MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis Todd Neale August 26, 2018
News Conference News ACC 2018 Apixaban Has Edge Over Other NOACs in Large, Real-World Analysis Todd Neale March 12, 2018
News Conference News AHA 2016 Incomplete Revascularization Linked With Increased MACE in Subsequent Noncardiac Surgery Michael O'Riordan November 15, 2016